NCT05644392 2022-12-09
A Study Evaluating Cadonilimab Injection in Combination With Regorafenib for the Treatment of Biliary Systemic Tumours
Tianjin Medical University Cancer Institute and Hospital
Phase 1 Unknown
Clinical Trials
1 trialsUnknown × Advanced Biliary Systemic Tumours That Has Failed at Least One Prior Systemic Therapy × regorafenib × Clear all